Vantage Investment Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $57K | Hold |
655
| – | – | 0.01% | 263 |
|
|
2018
Q2 | $65K | Hold |
655
| – | – | 0.02% | 238 |
|
|
2018
Q1 | $78K | Buy |
655
+400
| +157% | +$47.6K | 0.02% | 231 |
|
|
2017
Q4 | $32K | Buy |
255
+100
| +65% | +$12.5K | 0.01% | 369 |
|
|
2017
Q3 | $18K | Buy |
155
+128
| +474% | +$14.9K | ﹤0.01% | 452 |
|
|
2017
Q2 | $2K | Hold |
27
| – | – | ﹤0.01% | 700 |
|
|
2017
Q1 | $1K | Hold |
27
| – | – | ﹤0.01% | 727 |
|
|
2016
Q4 | $1K | Hold |
27
| – | – | ﹤0.01% | 742 |
|
|
2016
Q3 | $2K | Hold |
27
| – | – | ﹤0.01% | 677 |
|
|
2016
Q2 | $1K | Hold |
27
| – | – | ﹤0.01% | 757 |
|
|
2016
Q1 | $2K | Hold |
27
| – | – | ﹤0.01% | 703 |
|
|
2015
Q4 | $3K | Hold |
27
| – | – | ﹤0.01% | 659 |
|
|
2015
Q3 | $2K | Buy |
+27
| New | +$2K | ﹤0.01% | 697 |
|